Back to Search
LINDSEY WESTBROOK, MD
MD
Anatomic Pathology & Clinical Pathology Physician
NPI: 1376962399IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
A154391(CA)61827(CO)
CMS Specialties
PrimaryPATHOLOGY
Additional
GENERAL SURGERY
Education
UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE
Class of 2014
Research & Publications (19)
High Cks1 expression in transgenic and carcinogen-initiated mammary tumors is not always accompanied by reduction in p27Kip1.
PMID 19360356·Int J Oncol·2009
7-preclinical
Vascular endothelial growth factor reduces tamoxifen efficacy and promotes metastatic colonization and desmoplasia in breast tumors.
PMID 18676847·Cancer Res·2008
8-other
Cks1 regulates cdk1 expression: a novel role during mitotic entry in breast cancer cells.
PMID 18056467·Cancer Res·2007
8-other
Efficacy of rifabutin-loaded microspheres for treatment of Mycobacterium avium-infected macrophages and mice.
PMID 17454031·Drug Deliv·2007
7-preclinical
MEK ablation in MCF-7 cells blocks DNA synthesis induced by serum, but not by estradiol or growth factors.
PMID 17088999·Int J Oncol·2006
8-other
Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
PMID 16682955·Oncogene·2006
8-other
c-Abl-independent p73 stabilization during gemcitabine- or 4'-thio-beta-D-arabinofuranosylcytosine-induced apoptosis in wild-type and p53-null colorectal cancer cells.
PMID 16505115·Mol Cancer Ther·2006
8-other
Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
PMID 15231676·Cancer Res·2004
8-other
Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.
PMID 14980631·Bioorg Med Chem·2004
7-preclinical
Homogeneity and long-term stability of tetracycline-regulated gene expression with low basal activity by using the rtTA2S-M2 transactivator and insulator-flanked reporter vectors.
PMID 14960361·Gene·2004
7-preclinical
Challenges and strategies for conducting intervention research with culturally diverse populations.
PMID 11989230·J Transcult Nurs·2001
6-review
Premorbid psychiatric risk factors for postictal psychosis.
PMID 11748318·J Neuropsychiatry Clin Neurosci·2001
8-other
From theory to practice: community health nursing in a public health neighborhood team.
PMID 11104324·ANS Adv Nurs Sci·2000
8-other
Psychotropic medication use in patients with epilepsy: effect on seizure frequency.
PMID 11083162·J Neuropsychiatry Clin Neurosci·2000
8-other
Antimycobacterial activities of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductase.
PMID 10991861·Antimicrob Agents Chemother·2000
8-other
Timing of coronary stent thrombosis in patients treated with prophylactic tirofiban.
PMID 10973371·J Invasive Cardiol·2000
4-observational
Emotional outbursts and post-traumatic stress disorder during intracarotid amobarbital procedure.
PMID 10762519·Neurology·2000
5-case
Plant-derived and semi-synthetic calanolide compounds with in vitro activity against both human immunodeficiency virus type 1 and human cytomegalovirus.
PMID 10693651·Antivir Chem Chemother·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12605 E 16TH AVE
AURORA, CO 80045 - Phone
- (720) 848-0000
Quick Facts
- NPI
- 1376962399
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 12
- Publications
- 19
Are you this provider?
Claim Your Profile